Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A comprehensive review on solitary fibrous tumor: New insights for new horizons

  • Martín-Broto, Javier
  • Mondaza-Hernández, José L.
  • Moura, David S.
  • Hindi, Nadia
[Simple Summary] Solitary fibrous tumor (SFT) is a malignant condition that exhibits different clinical behaviors ranging from low to high aggressive SFT, with dedifferentiated SFT (DD-SFT) being the fastest-growing subtype. Even when surgery alone provides curation rates above 60%, recurrences do occur in a fraction of patients where surgery is unable to provide disease control. Among the systemic therapeutic options, antiangiogenic compounds have shown higher efficacy than chemotherapy by indirect comparisons. Furthermore, rotating different antiangiogenics, at the progression time, has been shown to be effective. The exception is DD-SFT since it is resistant to antiangiogenics but can respond to chemotherapy. This comprehensive review also analyzes the underlying molecular components that play a key role in SFT origin and aggressiveness. The discovery in 2013 of anomalous fusion genes between NAB2 and STAT6 was determinant to increase the knowledge on the molecular drivers in SFT that could be potential targets for future therapies., Solitary fibrous tumor (SFT) is a rare mesenchymal, ubiquitous tumor, with an incidence of 1 new case/million people/year. In the 2020 WHO classification, risk stratification models were recommended as a better tool to determine prognosis in SFT, to the detriment of “typical” or “malignant” classic terms. The risk for metastasis is up to 35–45%, or even greater, in series with a longer follow-up. Over the last few decades, advances in immunohistochemistry and molecular diagnostics identified STAT6 nuclear protein expression and the NAB2–STAT6 fusion gene as more precise tools for SFT diagnosis. Recent evidence taken from retrospective series and from two prospective phase II clinical trials showed that antiangiogenics are active and their sequential use from first line should be considered, except for dedifferentiated SFT for which chemotherapy is the best option. Since the fusion transcript driver’s first description in 2013, new insights have been brought on key molecular events in SFT. This comprehensive review mainly focuses on the superior efficacy of antiangiogenics over chemotherapeutic agents in SFT, provides the current knowledge of key molecules that could co-drive the SFT behavior, and suggests new target candidates that deserve to be explored in preclinical and clinical research in SFT., The authors would also like to thank the SELNET project. SELNET has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 825806. Furthermore, the authors would like to thank the Instituto de Salud Carlos III (ISCIII)—Fondo Europeo de Desarrollo Regional (FEDER), project reference PI18/01728. David S. Moura is the recipient of a Sara Borrell postdoctoral fellowship funded by the National Institute of Health Carlos III (ISCIII) (CD20/00155). José L. Mondaza-Hernandez is the recipient of a PFIS predoctoral fellowship funded by the National Institute of Health Carlos III (ISCIII) (FI19/00184).
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

SELNET clinical practice guidelines for bone sarcoma

  • Blay, Jean-Yves|||0000-0001-7190-120X
  • Palmerini, Emanuela|||0000-0003-3406-6705
  • Bollard, Julien|||0000-0002-9378-5665
  • Aguiar Júnior, Samuel|||0000-0003-3476-727X
  • Ángel, Martín Osvaldo|||0000-0002-1463-8887
  • Araya, Beatriz|||0000-0002-7804-0518
  • Badilla-González, Ronald
  • Bernabeu, Daniel|||0000-0003-0828-9104
  • Campos, Fernando|||0000-0002-7771-8059
  • Caro-Sanchez, Claudia Haydee Sarai
  • Carvajal Montoya, A.
  • Casavilca-Zambrano, Sandro|||0000-0001-8406-739X
  • Castro-Oliden, Victor|||0000-0003-2828-7325
  • Chacón, Matias|||0000-0001-6872-4185
  • Clara-Altamirano, Miguel Ángel
  • Collini, Paola|||0000-0002-6158-210X
  • Correa Genoroso, Raquel|||0000-0002-8212-8897
  • Costa, Felipe D.
  • Cuellar, M.
  • Dei Tos, Angelo|||0000-0002-1228-8940
  • Domínguez Malagón, Hugo Ricardo
  • Donati, Davide Maria|||0000-0002-9170-0576
  • Dufresne, Armelle
  • Eriksson, Mikael
  • Farias-Loza, M.
  • Frezza, Anna Maria|||0000-0003-2335-7224
  • Frisoni, Tommaso|||0000-0001-6109-3202
  • Garcia-Ortega, Dorian Yarih|||0000-0002-1302-2896
  • Gelderblom, Hans J.|||0000-0001-9270-8636
  • Gouin, François
  • Gómez-Mateo, María Carmen
  • Gronchi, Alessandro|||0000-0002-4703-3534
  • Haro-Varas, Juan|||0000-0003-0678-585X
  • Hindi, Nadia|||0000-0002-5864-762X
  • Huanca, Lourdes
  • Jimenez, Natalia|||0000-0002-7735-2341
  • Karanian, Marie
  • Kasper, Bernd|||0000-0001-8425-8356
  • Lopes, Artur
  • Lopes David, B.B.
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Lutter, Guido
  • Maki, Robert G.|||0000-0002-9853-2528
  • Martinez-Said, Héctor|||0000-0002-9881-4592
  • Martinez-Tlahuel, Jorge Luis
  • Mello, Celso A.|||0000-0002-8315-1562
  • Morales Pérez, José Manuel
  • Moura, David S.
  • Nakagawa, Suely Akiko
  • Nascimento, Antônio Geraldo
  • Ortiz Cruz, Eduardo J.|||0000-0002-1405-0688
  • Patel, Shreyaskumar|||0000-0002-0026-2348
  • Pfluger, Yanina
  • Provenzano, Salvatore|||0000-0003-0425-4692
  • Righi, Alberto
  • Rodriguez, Andrés
  • Santos, Telma G.
  • Scotlandi, Katia|||0000-0001-6114-9499
  • MLG, Silva
  • Soulé, Tomás
  • Stacchiotti, Silvia|||0000-0002-1742-8666
  • Valverde Morales, Claudia Maria
  • Waisberg, Federico Daniel|||0000-0003-4435-5068
  • Zamora Estrada, Esteban
  • Martín Broto, Javier|||0000-0001-7350-6916
Bone sarcoma are infrequent diseases, representing < 0.2% of all adult neoplasms. A multidisciplinary management within reference centers for sarcoma, with discussion of the diagnostic and therapeutic strategies within an expert multidisciplinary tumour board, is essential for these patients, given its heterogeneity and low frequency. This approach leads to an improvement in patient's outcome, as demonstrated in several studies. The Sarcoma European Latin-American Network (SELNET), aims to improve clinical outcome in sarcoma care, with a special focus in Latin-American countries. These Clinical Practice Guidelines (CPG) have been developed and agreed by a multidisciplinary expert group (including medical and radiation oncologist, surgical oncologist, orthopaedic surgeons, radiologist, pathologist, molecular biologist and representatives of patients advocacy groups) of the SELNET consortium, and are conceived to provide the standard approach to diagnosis, treatment and follow-up of bone sarcoma patients in the Latin-American context.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

SELNET clinical practice guidelines for soft tissue sarcoma and GIST

  • Blay, Jean-Yves|||0000-0001-7190-120X
  • Hindi, Nadia|||0000-0002-5864-762X
  • Bollard, Julien|||0000-0002-9378-5665
  • Aguiar Júnior, Samuel|||0000-0003-3476-727X
  • Ángel, Martín Osvaldo|||0000-0002-1463-8887
  • Araya, Beatriz|||0000-0002-7804-0518
  • Badilla-González, Ronald
  • Bernabeu, Daniel|||0000-0003-0828-9104
  • Campos, Fernando|||0000-0002-7771-8059
  • Caro-Sánchez, C.H.S.
  • Carvajal, B.
  • Carvajal Montoya, A.
  • Casavilca-Zambrano, Sandro|||0000-0001-8406-739X
  • Castro-Oliden, Victor|||0000-0003-2828-7325
  • Chacón, Matias|||0000-0001-6872-4185
  • Clara-Altamirano, Miguel Ángel
  • Collini, Paola|||0000-0002-6158-210X
  • Correa Genoroso, Raquel|||0000-0002-8212-8897
  • Costa, Felipe D.
  • Cuellar, M.
  • Dei Tos, Angelo|||0000-0002-1228-8940
  • Dominguez Malagón, Hugo Ricardo
  • Donati, Davide Maria|||0000-0002-9170-0576
  • Dufresne, Armelle
  • Eriksson, Mikael
  • Farias-Loza, M.
  • Fernandez, Piga|||0000-0002-7846-146X
  • Frezza, Anna Maria|||0000-0003-2335-7224
  • Frisoni, Tommaso|||0000-0001-6109-3202
  • Garcia-Ortega, Dorian Yarih|||0000-0002-1302-2896
  • Gelderblom, Hans J.|||0000-0001-9270-8636
  • Gouin, François
  • Gómez-Mateo, María Carmen
  • Gronchi, Alessandro|||0000-0002-4703-3534
  • Haro-Varas, Juan|||0000-0003-0678-585X
  • Huanca, Lourdes
  • Jimenez, Natalia|||0000-0002-7735-2341
  • Karanian, Marie
  • Kasper, Bernd|||0000-0001-8425-8356
  • Lopes David, B.B.
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Lutter, Guido
  • Martinez-Said, Héctor|||0000-0002-9881-4592
  • Martinez-Tlahuel, Jorge Luis
  • Mello, Celso A.|||0000-0002-8315-1562
  • Morales Pérez, José Manuel
  • Moura, David S.
  • Nascimento, Antônio Geraldo
  • Ortiz Cruz, Eduardo J.|||0000-0002-1405-0688
  • Palmerini, Emanuela|||0000-0003-3406-6705
  • Patel, Shreyaskumar|||0000-0002-0026-2348
  • Pfluger, Yanina
  • Provenzano, Salvatore|||0000-0003-0425-4692
  • Righi, Alberto
  • Rodriguez, Andrés
  • Salas, Rodrigo
  • Santos, Telma G.
  • Scotlandi, Katia|||0000-0001-6114-9499
  • Soulé, Tomás
  • Stacchiotti, Silvia|||0000-0002-1742-8666
  • Valverde Morales, Claudia Maria
  • Waisberg, Federico Daniel|||0000-0003-4435-5068
  • Zamora Estrada, Esteban
  • Martín Broto, Javier|||0000-0001-7350-6916